Page last updated: 2024-10-25

deferoxamine and Allodynia

deferoxamine has been researched along with Allodynia in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research Excerpts

ExcerptRelevanceReference
" In the present study, we evaluated RAc1 nano particle effects on hyperalgesia and liver hepcidin and serum IL-1β and TNF-α expression levels during acute and chronic phases of adjuvant-induced inflammation in male rats and compared its effects with Deferoxamine."3.91Anti-hyperalgesia effect of nanchelating based nano particle, RAc1, can be mediated via liver hepcidin expression modulation during persistent inflammation. ( Houshmandi, E; Kalanaky, S; Manaheji, H; Mirjafai, S; Mohammadi, M; Nazemian, V; Zaringhalam, J, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nazemian, V1
Kalanaky, S1
Manaheji, H1
Houshmandi, E1
Mohammadi, M1
Zaringhalam, J1
Mirjafai, S1

Other Studies

1 other study available for deferoxamine and Allodynia

ArticleYear
Anti-hyperalgesia effect of nanchelating based nano particle, RAc1, can be mediated via liver hepcidin expression modulation during persistent inflammation.
    International immunopharmacology, 2019, Volume: 69

    Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Deferoxamine; Hepcidins; Humans; Hyperalges

2019